BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

455 related articles for article (PubMed ID: 32855269)

  • 1. Loss of SWI/SNF Chromatin Remodeling Alters NRF2 Signaling in Non-Small Cell Lung Carcinoma.
    Song S; Nguyen V; Schrank T; Mulvaney K; Walter V; Wei D; Orvis T; Desai N; Zhang J; Hayes DN; Zheng Y; Major MB; Weissman BE
    Mol Cancer Res; 2020 Dec; 18(12):1777-1788. PubMed ID: 32855269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BRG1 interacts with Nrf2 to selectively mediate HO-1 induction in response to oxidative stress.
    Zhang J; Ohta T; Maruyama A; Hosoya T; Nishikawa K; Maher JM; Shibahara S; Itoh K; Yamamoto M
    Mol Cell Biol; 2006 Nov; 26(21):7942-52. PubMed ID: 16923960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brg1-mediated Nrf2/HO-1 pathway activation alleviates hepatic ischemia-reperfusion injury.
    Ge M; Yao W; Yuan D; Zhou S; Chen X; Zhang Y; Li H; Xia Z; Hei Z
    Cell Death Dis; 2017 Jun; 8(6):e2841. PubMed ID: 28569786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A synthetic lethality-based strategy to treat cancers harboring a genetic deficiency in the chromatin remodeling factor BRG1.
    Oike T; Ogiwara H; Tominaga Y; Ito K; Ando O; Tsuta K; Mizukami T; Shimada Y; Isomura H; Komachi M; Furuta K; Watanabe S; Nakano T; Yokota J; Kohno T
    Cancer Res; 2013 Sep; 73(17):5508-18. PubMed ID: 23872584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulation of SWI/SNF chromatin remodeling factor subunits modulates cisplatin cytotoxicity.
    Kothandapani A; Gopalakrishnan K; Kahali B; Reisman D; Patrick SM
    Exp Cell Res; 2012 Oct; 318(16):1973-86. PubMed ID: 22721696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Co-regulation of transcription by BRG1 and BRM, two mutually exclusive SWI/SNF ATPase subunits.
    Raab JR; Runge JS; Spear CC; Magnuson T
    Epigenetics Chromatin; 2017 Dec; 10(1):62. PubMed ID: 29273066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting of BRM Sensitizes
    Zernickel E; Sak A; Riaz A; Klein D; Groneberg M; Stuschke M
    Mol Cancer Ther; 2019 Mar; 18(3):656-666. PubMed ID: 30478150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene silencing associated with SWI/SNF complex loss during NSCLC development.
    Song S; Walter V; Karaca M; Li Y; Bartlett CS; Smiraglia DJ; Serber D; Sproul CD; Plass C; Zhang J; Hayes DN; Zheng Y; Weissman BE
    Mol Cancer Res; 2014 Apr; 12(4):560-70. PubMed ID: 24445599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulatory role of KEAP1 and NRF2 in PPARĪ³ expression and chemoresistance in human non-small-cell lung carcinoma cells.
    Zhan L; Zhang H; Zhang Q; Woods CG; Chen Y; Xue P; Dong J; Tokar EJ; Xu Y; Hou Y; Fu J; Yarborough K; Wang A; Qu W; Waalkes MP; Andersen ME; Pi J
    Free Radic Biol Med; 2012 Aug; 53(4):758-68. PubMed ID: 22684020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcriptional targets of the chromatin-remodelling factor SMARCA4/BRG1 in lung cancer cells.
    Medina PP; Carretero J; Ballestar E; Angulo B; Lopez-Rios F; Esteller M; Sanchez-Cespedes M
    Hum Mol Genet; 2005 Apr; 14(7):973-82. PubMed ID: 15731117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Degron mediated BRM/SMARCA2 depletion uncovers novel combination partners for treatment of BRG1/SMARCA4-mutant cancers.
    Rago F; DiMare MT; Elliott G; Ruddy DA; Sovath S; Kerr G; Bhang HC; Jagani Z
    Biochem Biophys Res Commun; 2019 Jan; 508(1):109-116. PubMed ID: 30527810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SWI/SNF complex is essential for NRSF-mediated suppression of neuronal genes in human nonsmall cell lung carcinoma cell lines.
    Watanabe H; Mizutani T; Haraguchi T; Yamamichi N; Minoguchi S; Yamamichi-Nishina M; Mori N; Kameda T; Sugiyama T; Iba H
    Oncogene; 2006 Jan; 25(3):470-9. PubMed ID: 16247481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of the SWI/SNF-ATPase subunit members SMARCF1 (ARID1A), SMARCA2 (BRM), SMARCA4 (BRG1) and SMARCB1 (INI1) in oesophageal adenocarcinoma.
    Schallenberg S; Bork J; Essakly A; Alakus H; Buettner R; Hillmer AM; Bruns C; Schroeder W; Zander T; Loeser H; Gebauer F; Quaas A
    BMC Cancer; 2020 Jan; 20(1):12. PubMed ID: 31906887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exquisite Sensitivity to Dual BRG1/BRM ATPase Inhibitors Reveals Broad SWI/SNF Dependencies in Acute Myeloid Leukemia.
    Rago F; Rodrigues LU; Bonney M; Sprouffske K; Kurth E; Elliott G; Ambrose J; Aspesi P; Oborski J; Chen JT; McDonald ER; Mapa FA; Ruddy DA; Kauffmann A; Abrams T; Bhang HC; Jagani Z
    Mol Cancer Res; 2022 Mar; 20(3):361-372. PubMed ID: 34799403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lung cancer with loss of BRG1/BRM, shows epithelial mesenchymal transition phenotype and distinct histologic and genetic features.
    Matsubara D; Kishaba Y; Ishikawa S; Sakatani T; Oguni S; Tamura T; Hoshino H; Sugiyama Y; Endo S; Murakami Y; Aburatani H; Fukayama M; Niki T
    Cancer Sci; 2013 Feb; 104(2):266-73. PubMed ID: 23163725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of Nrf2 promotes radiation-induced apoptosis through Nrf2 mediated Notch signaling in non-small cell lung cancer cells.
    Zhao Q; Mao A; Yan J; Sun C; Di C; Zhou X; Li H; Guo R; Zhang H
    Int J Oncol; 2016 Feb; 48(2):765-73. PubMed ID: 26691854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Propofol post-conditioning alleviates hepatic ischaemia reperfusion injury via BRG1-mediated Nrf2/HO-1 transcriptional activation in human and mice.
    Ge M; Chen H; Zhu Q; Cai J; Chen C; Yuan D; Jin Y; Yao W; Hei Z
    J Cell Mol Med; 2017 Dec; 21(12):3693-3704. PubMed ID: 28749008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular mechanisms for the regulation of Nrf2-mediated cell proliferation in non-small-cell lung cancers.
    Yamadori T; Ishii Y; Homma S; Morishima Y; Kurishima K; Itoh K; Yamamoto M; Minami Y; Noguchi M; Hizawa N
    Oncogene; 2012 Nov; 31(45):4768-77. PubMed ID: 22249257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alterations of the SWI/SNF chromatin remodelling subunit-BRG1 and BRM in hepatocellular carcinoma.
    Endo M; Yasui K; Zen Y; Gen Y; Zen K; Tsuji K; Dohi O; Mitsuyoshi H; Tanaka S; Taniwaki M; Nakanuma Y; Arii S; Yoshikawa T
    Liver Int; 2013 Jan; 33(1):105-17. PubMed ID: 23088494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SMARCA4/BRG1-Deficient Non-Small Cell Lung Carcinomas: A Case Series and Review of the Literature.
    Nambirajan A; Singh V; Bhardwaj N; Mittal S; Kumar S; Jain D
    Arch Pathol Lab Med; 2021 Jan; 145(1):90-98. PubMed ID: 33367658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.